back to top
e-alerts for this Journal

The email alerts service allows anyone who registers their email address to be notified via email when new content goes online.

Recommend this Journal

Recommend this journal to your friend or library.

Submit Manuscript

Manuscripts should be submitted online through our website or as an email attachment to the editorial office at

  • Latest Articles
  • Most Viewed

Latest Articles

Harnessing donor unrestricted T-cells for new vaccines against tuberculosis

13 May 2019

Specific knowledge gaps and research priorities that must be addressed to realize the full potential of DURTs as part of new TB... More

Optimization of a multivalent peptide vaccine for nicotine addiction

11 Mar 2019

Peptide which is produced by solid-phase protein synthesis, contains B cell and T cell epitope domains and eliminates the ... More

Vaccination associated acute disseminated encephalomyelitis

04 Feb 2019

The differential diagnosis of ADEM should exclude the possibility of infectious or other autoimmune encephalitis. ... More

Development of a live attenuated vaccine against Muscovy duck reovirus infection

06 Dec 2018

The CA strain exhibited striking genetic stability, excellent safety, and effective immunogenicity. This CA strain of MDRV is a... More

A framework for research on vaccine effectiveness

10 Nov 2018

Essential for understanding whether some diseases can be eliminated versus being controlled. The effectiveness of vaccines shou... More

Improving the stability of recombinant anthrax protective antigen vaccine

16 Oct 2018

Finding suggests that modification of Asn713 and Asn719 of rPA to deamidation-resistant amino acids may i... More

Polysaccharides as vaccine adjuvants

09 Aug 2018

Polysaccharide adjuvants will be developed and widely used in clinical practice with more in-depth investigations of polysaccha... More

The influence of the intestinal microbiome on vaccine responses

13 Jul 2018

Adequately powered studies using whole-genome sequencing are needed to investigate in more detail the influence of the int... More

Impact of a clinical interventions bundle on uptake of HPV vaccine at an OB/GYN clinic

05 Jun 2018

Implementation of this intervention bundle effectively reduced the monthly rate of MO and increased the prevalence of women who... More

Silk-based microneedle transdermal immunization with EV71 vaccines elicits potent immune response

05 Aug 2016

These findings suggest that inactivated EV71 virus was superior to rVP subunit vaccine in stimulating neutralizing antibody and... More

Most Viewed

Developing a vaccine for human rhinoviruses

01 Oct 2014

Rhinoviruses (RV’s) are common... More

Routine immunization services in Africa: back to basics

01 Jun 2013

National immunization programmes wer... More

Aims And Scope

Journal of Vaccines & Immunization (JVI) is an international refereed journal, which publishes high-quality original articles reporting new information on basic and clinical aspects of vaccines and immunization. The wide range of topics includes all types of vaccines, vaccine development, development of antibodies, purifying immunoglobulins, production, manufacturing, delivery, history of vaccinology and immunopathology. The journal covers relevant topics range from basic research to applications, safety, disease prevention, molecular biology, synthetic peptides, recombinant antigens and new immunogens.

Publication of article types

Original research: primary research from any area of Vaccines, Immunization, or Vaccines & Immunization related/interdisciplinary area.

Case reports: reports of clinical cases that can be educational, describe a diagnostic or therapeutic dilemma, suggest an association, or present an important adverse reaction.

Editorial: to introduce and comment on major advances and developments in the field.

Methodology: present a new experimental method, test or procedure. The method described may either be completely new, or may offer a better version of an existing method. The article must describe a demonstrable advance on what is currently available. The method needs to have been well tested ideally, but not necessarily, used in a way that proves its value.

News and commentary: short, focused and opinionated articles on any subject with in the journal’s scope. These articles are usually related to a contemporary issue, such as recent research findings, and are often written by opinion of leaders invited by the editorial board. Editorial board members and section editors may write such articles to highlight hot or emerging areas of research within a given field.

Rapid communications: devoted to the publication of short papers presenting highly original and significant material.

Review: to review systematically progress and unresolved problems in the field and make suggestions for future work. Comprehensive, authoritative, descriptions of any subject within the scope of Vaccines & Immunization journal.

Short reports: brief reports of data from original research.

Letters to the Editor: to discuss and make reply to the contributions published in JVI, or to introduce and comment on a controversial issue of general interest.

Publication frequency

All articles of JVI are posted online immediately as they are ready for publication. All articles will be assigned a DOI number (Digital Object Identifier) where they become searchable and citeable without delay.

Why publish in Journal of Vaccines & Immunization?

  • JVI offers scientists the opportunity to publish their research rapidly in an open access medium that is freely available online to researchers worldwide.
  • Electronic submission of manuscripts.
  • Immediate publication tentatively within a month/two months of Initial submission.
  • Efficient and objective peer review with a streamlined electronic production workflow.
  • No barriers, which helps your research reach the entire scientific community worldwide.
  • Our professional staff adds further value to your paper through the copy-editing process, which minimize stylistic errors and improves readability.
  • Our professional staff continuously working to improve the search engine rankings for NobleResearch group journals.
  • Our linking program extends too many abstracting and indexing databases, library sites, and includes participation in CrossRefTM.

Peer-review process

Peer-review is commonly accepted as an essential part of scientific publication. We appreciate the time that referees devote to assessing the manuscripts we send them, which helps to ensure that NobleResearch journals publish only material of the highest quality. Peer reviewers are asked to give their opinion on a number of issues pertinent to the scientific and formal aspects of a paper, and to judge the papers on grounds of originality and urgency. All relevant information will be forwarded to the author(s). There are several types of decision possible for each article.

  • Accept manuscript without revision
  • Accept after minor or major revision
  • Submit elsewhere, if the manuscript is better suited for another journal in our group
  • Reject manuscript, if the manuscript is substandard

In addition, papers may be rejected directly by the Chief Editor if judged to be out of scope or if scientifically or formally sub-standard. When asking for revisions, reviewers have two possible goals: to ask authors to tighten their arguments based on existing data, or to identify areas where more data are needed. Even formal revision may be required if the language or formalities is sub-standard. To facilitate rapid publication, authors are given a maximum of two months for revision. After two months, revised manuscripts will be considered as new submissions.


The review process is strictly confidential and should be treated as such by reviewers. Because the author may have chosen to exclude some people from this process, no one not directly involved with the manuscript, including colleagues or other experts in the field, should be consulted by the reviewer unless such consultations have first been discussed with the professional editor.

Timely review

NobleResearch believes that an efficient editorial process that results in timely publication provides a valuable service both to authors and to the scientific community at large. We therefore request that reviewers respond promptly, usually within fourteen (14) days of receipt of a manuscript. If reviewers need more time, we request that they contact us promptly so that we can keep the authors informed and, if necessary, assign alternative reviewers.

Supplemental files

Authors may and should take advantage of the web-based nature of the publication by submitting supplemental files that include animations, software demonstrations and innovative graphics. Supplemental files will be evaluated with the manuscript as part of the peer-review process. They should not exceed 20 megabytes in size. We accept the following file formats for supplemental files: TIF (tif), JPEG (jpg), GIF (gif), Animated GIF (gif), PostScript (ps), Encapsulated PostScript (eps), Adobe Photoshop (psd), AdobePDF (pdf), Audio (au), Audio (mp3), Audio (wav), MPEG (mpg), Quicktime (avi), Quicktime (mov).


Copyright on any open access article in a journal published by NobleResearch Publishers is retained by the author(s).

The Creative Commons Attribution License 4.0 formalizes these and other terms and conditions of publishing articles. In accordance with our Open Data policy, the Creative Commons CC0 1.0 Public Domain Dedication waiver applies to all published data in NobleResearch Publishers open access articles. Please contact us if there are any questions regarding Copyright policy.


Journal of Vaccines & Immunization offers a wide range of advertising opportunities to promote your product or service. NobleResearch group reserves the right to reject any advertisement not considered suitable for publication.

For more information please contact:

Marketing Director